human | Q5 |
P2671 | Google Knowledge Graph ID | /g/11bzsnd9wr |
P213 | ISNI | 000000011104287X |
P12541 | Ludzie Nauki ID (new) | MueuOIwACNx |
P1207 | NUKAT ID | n99044758 |
P7293 | PLWABN ID | 9810562746805606 |
P3124 | Polish scientist ID | 256508 |
P214 | VIAF ID | 161260959 |
P512 | academic degree | habilitation | Q308678 |
P734 | family name | Wojnar | Q8029234 |
Wojnar | Q8029234 | ||
Wojnar | Q8029234 | ||
P735 | given name | Andrzej | Q14941830 |
Andrzej | Q14941830 | ||
P106 | occupation | pathologist | Q3368718 |
oncologist | Q16062369 | ||
P21 | sex or gender | male | Q6581097 |
Q52337617 | Aberrant Expression of PIWIL1 and PIWIL2 and Their Clinical Significance in Ductal Breast Carcinoma. |
Q36250185 | Angiotensin II type 1 receptor (AT-1R) expression correlates with VEGF-A and VEGF-D expression in invasive ductal breast cancer |
Q79374099 | Association between pathologic response in metastatic lymph nodes after preoperative chemoradiotherapy and risk of distant metastases in rectal cancer: An analysis of outcomes in a randomized trial |
Q83890377 | CD24 expression is specific for tamoxifen-resistant ductal breast cancer cases |
Q85162394 | Cavernous haemangioma of the oviduct |
Q42950387 | Correlation between metallothionein (MT) expression and selected prognostic factors in ductal breast cancers. |
Q92048637 | Correlation of Expression of CHI3L1 and Nogo-A and their Role in Angiogenesis in Invasive Ductal Breast Carcinoma |
Q38413617 | Correlation of Ki-67 and MCM-2 proliferative marker expression with grade of histological malignancy (G) in ductal breast cancers |
Q84830895 | Correlation of intensity of MT-I/II expression with Ki-67 and MCM-2 proteins in invasive ductal breast carcinoma |
Q46439112 | Differences in oestrogen and progesterone receptors, HER-2, p53 expression and proliferation in ductal breast cancers in relation to histopathological grade |
Q46023402 | Differentiated expression of estrogen receptors (ER) and progesterone receptors (PgR) in ductal breast cancers. |
Q86300318 | Discrepancies between HER2 assessment from core needle biopsies and surgical specimens of invasive ductal breast carcinoma |
Q46394391 | Distal bowel surgical margin shorter than 1 cm after preoperative radiation for rectal cancer: is it safe? |
Q46985667 | Distal intramural spread of rectal cancer after preoperative radiotherapy: the results of a multicenter randomized clinical study |
Q47895470 | Evaluation of apoptosis, proliferation intensity and metallothionein (MT) expression in comparison with selected clinicopathological variables in primary adenocarcinomas of the large intestine. |
Q38393018 | Expression of SATB1 protein in the ductal breast carcinoma tissue microarrays - preliminary study |
Q39208543 | Expression of melatonin receptor MT1 in cells of human invasive ductal breast carcinoma |
Q38731339 | Expression of metallothionein 3 in ductal breast cancer |
Q89219396 | Expression of p16 and SATB1 in Invasive Ductal Breast Cancer - A Preliminary Study |
Q47810017 | Expression of periostin in breast cancer cells. |
Q38398888 | Hsp-27 expression in invasive ductal breast carcinoma |
Q54242111 | Impact of SOX18 expression in cancer cells and vessels on the outcome of invasive ductal breast carcinoma. |
Q95527487 | Impact of different tumour stroma assessment methods regarding podoplanin expression on clinical outcome in patients with invasive ductal breast carcinoma |
Q83229747 | Infralevator lymphatic drainage of low-rectal cancers: preliminary results |
Q80385410 | Lack of relationship between metallothionein (MT) expression and proliferation exponents in cells of primary ductal breast cancer of G2 grade of differentiation |
Q52933305 | Maspin expression is characteristic for cisplatin-sensitive ovarian cancer cells and for ovarian cancer cases of longer survival rates. |
Q54292996 | Matrix metalloproteinase (MMP)-2 and MMP-9 expression in tumor infiltrating CD3 lymphocytes from women with endometrial cancer. |
Q54333727 | Podoplanin expression by cancer-associated fibroblasts predicts poor outcome in invasive ductal breast carcinoma. |
Q40676851 | Prognostic Significance of NOGO-A/B and NOGO-B Receptor Expression in Malignant Melanoma - A Preliminary Study |
Q44368912 | Prognostic value of immunocytochemical determination of parathyroid hormone-related peptide expression in cells of mammary ductal carcinoma. Analysis of 7 years of the disease course. |
Q24813854 | Relationship between the expression of cyclooxygenase 2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significance |
Q45201964 | Steroid receptor status, proliferation and metallothionein expression in primary invasive ductal breast cancers |
Q79805609 | Stromal myofibroblasts in breast cancer: relations between their occurrence, tumor grade and expression of some tumour markers |
Q58605865 | Sulfatide decreases the resistance to stress-induced apoptosis and increases P-selectin-mediated adhesion: a two-edged sword in breast cancer progression |
Q88923599 | The Role of CHI3L1 Expression in Angiogenesis in Invasive Ductal Breast Carcinoma |
Q79343622 | The expression of selected immunocytochemical diagnostic markers in the case of chondrosarcoma with a mesenchymal component |
Q53130268 | Therapeutic radiation induces different changes in expression profiles of metallothionein (MT) mRNA, MT protein, Ki 67 and minichromosome maintenance protein 3 in human rectal adenocarcinoma. |
Q38404863 | Tissue microarray technique in evaluation of proliferative activity in invasive ductal breast cancer |
Q84132829 | Tumour regression grading in patients with residual rectal cancer after preoperative chemoradiation |
Q81674092 | [The relationship of the expression of proliferetron--related antigens Ki67 and PCNA in the cells of ductal breast cancer with the differentiation grade] |
Andrzej Wojnar | wikipedia |
Search more.